RPM Remote Patient Monitoring
RPM Remote Patient Monitoring is partnering with Chronisense to use a soon-to-be FDA approved wristwatch in 2020, which measures respiratory rate, heart rate, pulse oximetry and ekg. This medical device will be billable via medicare and commercial insurance with reimbursement set at $1500 per patient. We anticipate $1.5 million first year revenues.
Four lucky start-ups will be selected to present at our RipTide finale event on November 9th. So if you like this idea and think it should make the final, please add your comments and rating below. The more positive comments a start-up gets, the more likely it will be picked to be a finalist.
To join us at the finale event on Nov 9th, please RSVP now. Limited seats available.
Please check out other start-up entries here.
Riptide 2019 Sponsors
Thank you to our generous sponsors and patrons, without whom we could not have made the Riptide grants possible.